Serum sCD40L and galectin-3 in the prognosis prediction of patients with acute ischemic stroke

Zhiqin Chen, Quanhua Xiao, Kunqing Luo, Lin Shuping, Fan Zhaoyang, Xianliang Lai · 2026

Read Serum sCD40L and galectin-3 in the prognosis prediction of patients with acute ischemic stroke by Zhiqin Chen, Quanhua Xiao, Kunqing Luo, Lin Shuping, Fan Zhaoyang, Xianliang Lai (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13599527.txt.

Description

Zhiqin Chen and co-authors tested in 2026 whether two blood marks can foresee how stroke patients fare. One hundred eighty patients with acute ischemic stroke got clot-busting care plus a standard drug. Blood levels of sCD40L and galectin-3 were read before care and four weeks on. Patients were split by how well care worked and by their three-month function scores.

About a fifth fared poorly. Both marks ran higher in that group and in those the care failed, and lower after care in those it helped. High levels of each mark raised the odds of poor outcomes in joint models. Curve tests showed fair forecast skill for each. The team pitches the pair as cheap warning flags in stroke care.

Catalog record

CREATORZhiqin Chen, Quanhua Xiao, Kunqing Luo, Lin Shuping, Fan Zhaoyang, Xianliang Lai
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE29 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13599527

Browse the full library · About the Tower of Babel